Skip to content

Observational Study of IgE-Mediated Leguminous Allergies in a Pediatric Population

Observational Study of IgE-Mediated Leguminous Allergies in a Pediatric Population

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07811141
Acronym
FabALL
Enrollment
100
Registered
2026-09-09
Start date
2026-09-01
Completion date
2034-09-01
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypersensitivity, Food, Legumes Allergy

Keywords

food hypersensitivity, allergy, fabaceae, leguminous, biobank

Brief summary

Prospective, monocentric, observational study with standard care follow-up during 5 years or until the patient reaches the age of 18. The aim of this study is to prospectively and comprehensively assess the characteristics of patients aged 6 months to 17 years with leguminous allergy (excluding peanut) and their reactions to leguminous, including both medical history and prospective follow-up for 5 years from inclusion, or until the age of 18. The study aims to improve the understanding of these allergies, provide epidemiological data, and optimize diagnostic and clinical management. A biobank will also be established, with plasma (one whole blood sample collected at the inclusion) in order to validate future diagnostic tests.

Interventions

None listed

Sponsors

University Hospital, Lille
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Months to 17 Years
Healthy volunteers
No

Inclusion criteria

* Subjects aged 6 months to 17 years old * Medical diagnosis of allergy to one or more leguminous : * Clinical reaction following real-life exposure AND positive skin and/or biological sensitization * Allergy confirmed by a positive oral food challenge (OFC) in cases of sensitization without a history of clinical reaction * Subjects seen in a pediatric pneumo-allergy unit (consultation or hospitalization)

Exclusion criteria

* Isolated IgE-mediated peanut allergy * Patients aged 18 years or older * Minor patient or legal representant (parental authority) Refusal

Design outcomes

Primary

MeasureTime frameDescription
Prospectively study, among the leguminous, the type of leguminous (excluding peanut) responsible for the allergy.Baseline (Inclusion) 1 Year from the Inclusion 5 years from the inclusion, or until the age of 18The primary endpoint will be the number of allergy diagnoses for each type of leguminous (excluding peanut), among : * Green peas * Split peas (dried green peas) * Yellow or blond dried peas * Chickpeas * Green, red, or blond lentils * Green, Kidney, White or Mung beans * Soybean * Lupin * Fenugreek * Fava bean (broad bean) * Beluga lentils * Black-eyed peas (cowpeas), adzuki beans,and urad beans * Alfalfa

Secondary

MeasureTime frame
Describe the age at onset and severity of the first manifestationBaseline (Inclusion)
Describe quality of life (FAQLQ questionnaires) in children aged 8 years or olderBaseline (Inclusion)
Establish a biobank (blood - plasma samples) to validate future diagnostic testsBaseline (Inclusion)
Describe the severity of reactions by legume (FASS score)Baseline (Inclusion) 1 Year from the Inclusion 5 years from the inclusion, or until the age of 18
Describe the frequency of anaphylaxis by legume (according to the WAO definition)Baseline (Inclusion) 1 Year from the Inclusion 5 years from the inclusion, or until the age of 18
Describe the frequency of severe anaphylaxis by legume (FASS-5 Grades 4 and 5)Baseline (Inclusion) 1 Year from the Inclusion 5 years from the inclusion, or until the age of 18
Describe associations between allergies to different leguminous.Baseline (Inclusion) 1 Year from the Inclusion 5 years from the inclusion, or until the age of 18
Describe allergic comorbidities (asthma, rhinitis, atopic dermatitis, and pollinosis)Baseline (Inclusion) 1 Year from the Inclusion 5 years from the inclusion, or until the age of 18
Describe associated food allergies, including peanut and other foodsBaseline (Inclusion) 1 Year from the Inclusion 5 years from the inclusion, or until the age of 18
Describe allergy management strategies: targeted avoidance, broad avoidance, emergency kit with an adrenaline auto-injector, and school-based management (Individualized Healthcare Plan)Baseline (Inclusion) 1 Year from the Inclusion 5 years from the inclusion, or until the age of 18
Assess parents' knowledge of the different leguminousBaseline (Inclusion) 1 Year from the Inclusion 5 years from the inclusion, or until the age of 18
Prospectively assess allergic reactions in real-life settings: number of reactions, severity, type of food (prepackaged ready-made meal or homemade meal), labeling, quantity consumed, location of occurrence, and managementBaseline (Inclusion) 1 Year from the Inclusion 5 years from the inclusion, or until the age of 18

Countries

France

Contacts

CONTACTCeline CLAIRET-LESPINASSE
celine.clairet@chu-lille.fr+33 3204441145
CONTACTDRS. Promotion
drs.promotion@chu-lille.fr+33 3204441145

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026